COT-17 EFFECT OF BEVACIZUMAB AGAINST CYSTIC COMPONENT OF PRIMARY/METASTATIC BRAIN TUMORS

BACKGROUND: Bevacizumab (BEV) improves the symptom via reducing the peritumoral edema and sometimes via reducing the size of brain tumor. However,the effect of BEV against cystic part of brain tumor has not been documented yet. In this report,we investigated the effect of BEV on cystic component of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neurooncol Adv
Huvudupphovsmän: Yamasaki, Fumiyuki, Takano, Motoki, Yonezawa, Ushio, Taguchi, Akira, Onishi, Shumpei, Kurisu, Kaoru, Sugiyama, Kazuhiko
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2019
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213219/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.197
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk